Thrombospondin-1 and Pathogenesis of Age-Related Macular Degeneration

被引:12
|
作者
Housset, Michael [1 ,2 ,3 ]
Sennlaub, Florian [1 ,2 ,3 ,4 ]
机构
[1] Univ Paris 06, Sorbonne Univ, Inst Vis, UMR S 968, Paris, France
[2] CNRS, UMR 7210, Paris, France
[3] INSERM, U968, Paris, France
[4] DHU ViewMaintain, INSERM DHOS CIC 1423, Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France
基金
欧洲研究理事会; 芬兰科学院;
关键词
INDUCED MACROPHAGE APOPTOSIS; RETINAL DEGENERATION; IMMUNE PRIVILEGE; BRUCHS MEMBRANE; MOUSE MODEL; T-CELLS; ANGIOGENESIS; INFLAMMATION; ACTIVATION; EXPRESSION;
D O I
10.1089/jop.2015.0023
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The cardinal features of age-related macular degeneration (AMD) are the accumulation of subretinal debris, subretinal inflammation, neovascularization, and degeneration of the photoreceptors and retinal pigment epithelium (RPE). Thrombospondin-1 (TSP-1) is a major matricellular protein that is physiologically expressed in the RPE and choroid, but severely diminished in eyes with AMD. TSP-1 plays an important role in phagocytosis, potently inhibits neovascularization, and mediates immune suppression and immune privilege. The lack of TSP-1 could have a central role in the pathogenesis of AMD as it is implicated in the major pathways that seem to be deficient in the disease. We here give an overview of the major functions of TSP-1 and how it could intervene in AMD pathogenesis.
引用
收藏
页码:406 / 412
页数:7
相关论文
共 50 条
  • [21] Age-related macular degeneration (AMD): pathogenesis and therapy
    Nowak, Jerzy Z.
    PHARMACOLOGICAL REPORTS, 2006, 58 (03) : 353 - 363
  • [22] Pathogenesis and treatments of age-related macular degeneration (AMD)
    Nowak, JZ
    PHARMACOLOGICAL REPORTS, 2006, 58 (02) : 283 - 284
  • [23] The role of inflammation in the pathogenesis of age-related macular degeneration
    Donoso, LA
    Kim, D
    Frost, A
    Callahan, A
    Hageman, G
    SURVEY OF OPHTHALMOLOGY, 2006, 51 (02) : 137 - 152
  • [24] PATHOGENESIS OF AGE-RELATED MACULAR DEGENERATION - EMBRYOLOGIC CONCEPT
    KASHANI, AA
    ANNALS OF OPHTHALMOLOGY, 1990, 22 (07): : 246 - 248
  • [25] Current concepts in the pathogenesis of age-related macular degeneration
    Zarbin, MA
    ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (04) : 598 - 614
  • [26] Thrombospondin-1 proteomimetic polymers exhibit anti-angiogenic activity in a neovascular age-related macular degeneration mouse model
    Choi, Wonmin
    Nensel, Ashley K.
    Droho, Steven
    Fattah, Mara A.
    Mokashi-Punekar, Soumitra
    Swygart, David I.
    Burton, Spencer T.
    Schwartz, Greg W.
    Lavine, Jeremy A.
    Gianneschi, Nathan C.
    SCIENCE ADVANCES, 2023, 9 (41)
  • [27] THE ROLE OF REDUCED PHAGOCYTOSIS IN THE PATHOGENESIS OF AGE-RELATED MACULAR DEGENERATION
    Caruso, Emily
    Gu, Ben
    Fletcher, Erica
    Huang, Xin
    Avula, Pavan
    Guymer, Robyn
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 : 119 - 119
  • [28] AGE-RELATED MACULAR DEGENERATION: CURRENT ASPECTS OF PATHOGENESIS AND TREATMENT
    H P Heidenkummer
    眼科学报, 1991, (01) : 6 - 20
  • [29] The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration
    Friedman, E
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 130 (05) : 658 - 663
  • [30] Histopathology of Age-Related Macular Degeneration and Implications for Pathogenesis and Therapy
    Chee, Ru-ik
    Mahrous, Abdallah
    Koenig, Lisa
    Mandel, Lindsay Skye
    Yazdanie, Fahd
    Chan, Chi-Chao
    Gupta, Mrinali P.
    AGE-RELATED MACULAR DEGENERATION: FROM CLINIC TO GENES AND BACK TO PATIENT MANAGEMENT, 2021, 1256 : 67 - 88